Re-linkage to Care of Patients With Hepatitis C

NCT04470271 | Unknown

• 1 other identifier: CIE N° P 20-008
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to identify patients with chronic hepatitis C virus (HCV) who were lost of follow up and relinkage them to hepatitis C care

Conditions

Viral Hepatitis C

Keywords

viral infection; outcome; antiviral therapy

Outcome Measures

Primary Outcomes (1)

• Number of participants who were lost of follow up

  Participants are going to be contacted by phone or email to evaluate if they are under HCV care

  through study completion, an average of 6 months

Study Arms (2)

Patients under routine hepatitis C care

Patients who are routinely followed at the treating institution. Investigators will evaluate baseline demographic, liver fibrosis stage, liver-related complications, and antiviral therapy.

Patients with hepatitis C lost of follow-up

Patients who were lost of follow-up. Participants will be contacted to evaluate if the continued HCV care at another institution, were not routinely followed by a liver-specialist or if they died. Investigators will also evaluate baseline demographic, liver fibrosis stage, liver-related complications, and antiviral therapy.

Other: Patients with hepatitis C lost follow up

Interventions

Patients with hepatitis C lost follow up OTHER

Patients with chronic HCV who were lost of follow up will be contacted by phone or email. At least 3 phone calls will be made on three different days. In case the patient is not contacted it will be considered lost of follow-up

Patients with hepatitis C lost of follow-up

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult patients with history of chronic HCV infection who were lost of follow up.

You may qualify if:

• Patients older than 18 years
• Patients clinically evaluated at least once in the participating medical center
• chronic HCV infection

Sponsors & Collaborators

• Austral University, Argentina: lead

Study Sites (1)

Universidad Austral

Pilar, Buenos Aires, 1629, Argentina

Location

MeSH Terms

Conditions

Hepatitis C; Virus Diseases

Condition Hierarchy (Ancestors)

Blood-Borne Infections; Communicable Diseases; Infections; Hepatitis, Viral, Human; Flaviviridae Infections; RNA Virus Infections; Hepatitis; Liver Diseases; Digestive System Diseases

Study Officials

• Marcelo O Silva, MD

  Austral University, Argentina

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Manuel Mendizabal, MD

CONTACT

+5491140332244; mmendiza@cas.austral.edu.ar

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Target Duration: 6 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Coordinator

Study Record Dates

• First Submitted: July 4, 2020
• First Posted: July 14, 2020
• Study Start: September 1, 2020
• Primary Completion: December 31, 2020
• Study Completion: March 31, 2021
• Last Updated: July 14, 2020

Record last verified: 2020-07

Data Sharing

• IPD Sharing: Will not share

Locations

AR (1)